跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“AAAAI”
全部
24
临床试验
2
药物
0
机构
0
资讯
22
去年
Sanofi to Present Extensive Immunology Data at AAAAI 2025, Highlighting Dupixent and Pipeline Advances
7个月前
ADARx Pharmaceuticals to Present Phase 1/2 Data for Onvuzosiran siRNA Therapy at AAAAI 2026 Meeting
7个月前
Regeneron Unveils First-in-Class Phase 3 Data for Novel Cat and Birch Allergy Treatments at AAAAI 2026
7个月前
Septerna Advances MRGPRX2 Inhibitor SEP-631 to Clinical Testing for Chronic Urticaria and Mast Cell Disorders
去年
LongBio's LP-003 Receives IND Approval in China for Food Allergy Treatment
去年
Omalizumab Approval and Media Impact Highlight Top Food Allergy Stories of 2024
去年
Xolair Study Shows Promise: Majority of Children Successfully Consume Allergens After Treatment Discontinuation
去年
Seismic Therapeutic's Novel IgE Protease S-8484 Shows Promise in Preclinical Allergic Disease Studies
去年
Anaphylm Shows Consistent Efficacy Despite Oral Allergy Syndrome Complications
去年
Tezepelumab Shows 79% Reduction in Severe Asthma Exacerbations in Real-World Study
第 1 页,共 3 页
上一页
下一页